Statin Therapy for Primary Prevention Guided by 7.5% ASCVD Risk Threshold, Experts Say

Experts say statin therapy for primary prevention requires careful consideration of both cardiovascular risk factors and potential side effects. Discussions centered on balancing the benefits against adverse effects like myalgia and liver abnormalities. Doctors generally favor statin treatment when a patient’s calculated 10-year atherosclerotic cardiovascular disease (ASCVD) risk exceeds 7.5% to 10%. Panelists stated that individual patient factors further guide treatment recommendations. These factors include age, existing health conditions, and patient preferences. According to the experts, this customized approach ensures that statin therapy aligns with each patient’s specific needs and circumstances.

Newsflash | Powered by GeneOnline AI
Date: April 28, 2025

Related posts:

HHS Review Recommends Behavioral Therapy First for Gender Dysphoric Youth, Cites Cautious Approach to Medical Interventions Specialty Pharmacies Mandated to Develop Health Equity Programs Addressing Diverse Patient Needs Pharmacists Aid Non-Small Cell Lung Cancer Patients Through Education, Personalized Medication Schedules, and Insurance Navigation. TAE Life Sciences and OSUCCC – James Partner to Develop Boron-Based Cancer Therapies

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後